133 related articles for article (PubMed ID: 1967223)
1. Activities of newly synthesized dihydropyridines in overcoming of vincristine resistance, calcium antagonism, and inhibition of photoaffinity labeling of P-glycoprotein in rodents.
Kiue A; Sano T; Suzuki K; Inada H; Okumura M; Kikuchi J; Sato S; Kohno K; Kuwano M
Cancer Res; 1990 Jan; 50(2):310-7. PubMed ID: 1967223
[TBL] [Abstract][Full Text] [Related]
2. Reversal by two dihydropyridine compounds of resistance to multiple anticancer agents in mouse P388 leukemia in vivo and in vitro.
Kiue A; Sano T; Naito A; Inada H; Suzuki K; Okumura M; Kikuchi J; Sato S; Takano H; Kohno K
Jpn J Cancer Res; 1990 Oct; 81(10):1057-64. PubMed ID: 1977728
[TBL] [Abstract][Full Text] [Related]
3. Circumvention of multidrug resistance by a newly synthesized quinoline derivative, MS-073.
Sato W; Fukazawa N; Suzuki T; Yusa K; Tsuruo T
Cancer Res; 1991 May; 51(9):2420-4. PubMed ID: 1673087
[TBL] [Abstract][Full Text] [Related]
4. Analysis of structural features of dihydropyridine analogs needed to reverse multidrug resistance and to inhibit photoaffinity labeling of P-glycoprotein.
Nogae I; Kohno K; Kikuchi J; Kuwano M; Akiyama S; Kiue A; Suzuki K; Yoshida Y; Cornwell MM; Pastan I
Biochem Pharmacol; 1989 Feb; 38(3):519-27. PubMed ID: 2563655
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of the vincristine effect on P388 mouse leukemia cells by a newly synthesized dihydropyridine analogue, PAK-200.
Shudo N; Fujii R; Matsumoto T; Mizoguchi T; Seto K; Sakoda R; Akiyama S
Jpn J Cancer Res; 1992 Sep; 83(9):1011-7. PubMed ID: 1429198
[TBL] [Abstract][Full Text] [Related]
6. Correlation between reversing of multidrug resistance and inhibiting of [3H]azidopine photolabeling of P-glycoprotein by newly synthesized dihydropyridine analogues in a human cell line.
Kamiwatari M; Nagata Y; Kikuchi H; Yoshimura A; Sumizawa T; Shudo N; Sakoda R; Seto K; Akiyama S
Cancer Res; 1989 Jun; 49(12):3190-5. PubMed ID: 2566378
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of etoposide and vincristine by two synthetic 1,4-dihydropyridine derivatives in multidrug-resistant and atypical multidrug-resistant human cancer cells.
Watanabe Y; Takano H; Kiue A; Kohno K; Kuwano M
Anticancer Drug Des; 1991 Feb; 6(1):47-57. PubMed ID: 2015041
[TBL] [Abstract][Full Text] [Related]
8. N-alkylated 1,4-dihydropyridines: new agents to overcome multidrug resistance.
Ohsumi K; Ohishi K; Morinaga Y; Nakagawa R; Suga Y; Sekiyama T; Akiyama Y; Tsuji T; Tsuruo T
Chem Pharm Bull (Tokyo); 1995 May; 43(5):818-28. PubMed ID: 7553968
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of antitumour activity of etoposide by dihydropyridines on drug-sensitive and drug-resistant leukaemia in mice.
Kiue A; Sano T; Naito A; Okumura M; Kohno K; Kuwano M
Br J Cancer; 1991 Aug; 64(2):221-6. PubMed ID: 1892749
[TBL] [Abstract][Full Text] [Related]
10. Reversal of multidrug resistance by a novel quinoline derivative, MS-209.
Sato W; Fukazawa N; Nakanishi O; Baba M; Suzuki T; Yano O; Naito M; Tsuruo T
Cancer Chemother Pharmacol; 1995; 35(4):271-7. PubMed ID: 7828268
[TBL] [Abstract][Full Text] [Related]
11. Effect of newly synthesized indole derivatives on multidrug resistance in human cancer cells.
Matsumoto T; Fujii R; Sugita M; Sumizawa T; Sakai S; Takahashi T; Sueda N; Furukawa T; Akiyama S; Nagata Y
Anticancer Drug Des; 1994 Jun; 9(3):251-61. PubMed ID: 7913322
[TBL] [Abstract][Full Text] [Related]
12. In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52.
Shinoda H; Inaba M; Tsuruo T
Cancer Res; 1989 Apr; 49(7):1722-6. PubMed ID: 2924316
[TBL] [Abstract][Full Text] [Related]
13. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
[TBL] [Abstract][Full Text] [Related]
14. Newly synthesized dihydropyridine derivatives as modulators of P-glycoprotein-mediated multidrug resistance.
Tanabe H; Tasaka S; Ohmori H; Gomi N; Sasaki Y; Machida T; Iino M; Kiue A; Naito S; Kuwano M
Bioorg Med Chem; 1998 Nov; 6(11):2219-27. PubMed ID: 9881113
[TBL] [Abstract][Full Text] [Related]
15. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
Friche E; Demant EJ; Sehested M; Nissen NI
Br J Cancer; 1993 Feb; 67(2):226-31. PubMed ID: 8094288
[TBL] [Abstract][Full Text] [Related]
16. In vivo reversal of multidrug resistance by two new dihydropyridine derivatives, S16317 and S16324.
Kraus-Berthier L; Guilbaud N; Peglion JL; Leonce S; Lombet A; Pierre A; Atassi G
Acta Oncol; 1994; 33(6):631-7. PubMed ID: 7946440
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure--activity analysis of novel dihydropyridine derivatives to overcome multidrug resistance.
Tasaka S; Ohmori H; Gomi N; Iino M; Machida T; Kiue A; Naito S; Kuwano M
Bioorg Med Chem Lett; 2001 Jan; 11(2):275-7. PubMed ID: 11206476
[TBL] [Abstract][Full Text] [Related]
18. Reversal of P-glycoprotein associated multidrug resistance by new isoprenoid derivatives.
Hayashi M; Koike K; Rho MC; Kuwano M; Kishiye T; Komiyama K
Anticancer Drug Des; 2001; 16(4-5):255-60. PubMed ID: 12049484
[TBL] [Abstract][Full Text] [Related]
19. Effect of a dihydropyridine analogue, 2-[benzyl(phenyl)amino]ethyl 1,4-dihydro-2,6-dimethyl-5-(5,5-dimethyl-2-oxo- 1,3,2-dioxaphosphorinan-2-yl)-1-(2-morpholinoethyl)-4-(3-nitrophenyl)-3 -pyridinecarboxylate on reversing in vivo resistance of tumor cells to adriamycin.
Niwa K; Yamada K; Furukawa T; Shudo N; Seto K; Matsumoto T; Takao S; Akiyama S; Shimazu H
Cancer Res; 1992 Jul; 52(13):3655-60. PubMed ID: 1617639
[TBL] [Abstract][Full Text] [Related]
20. Acquired vs innate multidrug resistance and the effect of calcium channel blockers.
Tsuruo T
Prog Clin Biol Res; 1986; 223():203-16. PubMed ID: 3468516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
